Cannabinoid Encyclopedia

Safety guide

Dependence and withdrawal: what to know

A source-linked guide to Dependence and withdrawal, the situations researchers have examined, and the details that can change risk.

Updated July 2026 9 research sources Source-linked research review

The short answer

Why does Dependence and withdrawal matter?

Dependence and withdrawal is an important cannabinoid safety topic. Studies and reviews examine THC. This page brings together 9 research reviews. The available sources help map the question but do not support a broad conclusion. The compound, dose, route, other medications, and individual health context all matter. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about Dependence and withdrawal.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on Dependence and withdrawal covers THC; those areas should not be combined into one claim. 1

  2. 2

    The available sources help map the question but do not support a broad conclusion. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about Dependence and withdrawal

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Too limited for a firm answer

THC

Research involving THC contributes to the larger Dependence and withdrawal question. Risk can change with dose, route, formulation, other substances, medications, and the person being studied. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

Not prominent

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

9 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

Not prominent

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on Dependence and withdrawal is not one kind of study. This source set includes 6 systematic reviews or meta-analyses and 3 narrative or expert reviews. 3

The recorded populations or models include people or patients (6 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is dependence or withdrawal outcomes (9 sources). Closely related outcome names can still describe different measurements. 5

The Dependence and withdrawal source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

systematic review or meta-analysis

Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies.

On this page, this source examines THC and dependence and withdrawal. 1

Study type
systematic review or meta-analysis
Population or model
people or patients
Outcome focus
dependence or withdrawal outcomes
Evidence stage
evidence still limited

systematic review or meta-analysis

Pharmacotherapies for cannabis use disorder.

On this page, this source examines THC and dependence and withdrawal. 2

Study type
systematic review or meta-analysis
Population or model
people or patients
Outcome focus
dependence or withdrawal outcomes
Evidence stage
evidence still limited

systematic review or meta-analysis

Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.

On this page, this source examines THC and dependence and withdrawal. 3

Study type
systematic review or meta-analysis
Population or model
people or patients
Outcome focus
dependence or withdrawal outcomes
Evidence stage
evidence still limited

systematic review or meta-analysis

Pharmacotherapies for cannabis dependence.

On this page, this source examines THC and dependence and withdrawal. 4

Study type
systematic review or meta-analysis
Population or model
people or patients
Outcome focus
dependence or withdrawal outcomes
Evidence stage
evidence still limited

systematic review or meta-analysis

Pharmacotherapies for cannabis dependence.

On this page, this source examines THC and dependence and withdrawal. 5

Study type
systematic review or meta-analysis
Outcome focus
dependence or withdrawal outcomes
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

This page is already focused on Dependence and withdrawal. Risk can change with the cannabinoid, amount, route, frequency, formulation, other substances, medications, age, pregnancy, and underlying health conditions. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What is the main research question about Dependence and withdrawal?

The literature on this page centers on THC. The available sources help map the question but do not support a broad conclusion. 7

How should I read the sources?

Start with the study design, then check the product, dose, route, population, outcome, and safety information. 8

Does this page give medical advice?

No. It explains published research and links to sources; it does not provide a diagnosis, treatment plan, or personal dosing advice. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies. systematic review or meta-analysis; evidence still limited PubMed 36434879 DOI 10.1016/j.drugalcdep.2022.109702
  2. 2
    Pharmacotherapies for cannabis use disorder. systematic review or meta-analysis; evidence still limited PubMed 41025421 DOI 10.1002/14651858.cd008940.pub4
  3. 3
    Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. systematic review or meta-analysis; evidence still limited PubMed 35510826 DOI 10.1002/14651858.cd013444.pub2
  4. 4
    Pharmacotherapies for cannabis dependence. systematic review or meta-analysis; evidence still limited PubMed 30687936 DOI 10.1002/14651858.cd008940.pub3
  5. 5
    Pharmacotherapies for cannabis dependence. systematic review or meta-analysis; evidence still limited PubMed 25515775 DOI 10.1002/14651858.cd008940.pub2
  6. 6
    The differential effects of medicinal cannabis on mental health: A systematic review. systematic review or meta-analysis; evidence still limited PubMed 40186931 DOI 10.1016/j.cpr.2025.102581
  7. 7
    [Cannabis use and cannabis use disorders]. narrative or expert review; evidence still limited PubMed 39134752 DOI 10.1007/s00115-024-01722-5
  8. 8
    Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. narrative or expert review; evidence still limited PubMed 19367504 DOI 10.1080/09540260902782752
  9. 9
    Clinical management of cannabis withdrawal. narrative or expert review; evidence still limited PubMed 34791767 DOI 10.1111/add.15743
See all 9 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Pharmacotherapies for cannabis use disorder. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 41025421
  2. Clinical management of cannabis withdrawal. narrative or expert review; evidence still limited / 1 linked research note PubMed 34791767
  3. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 35510826
  4. The differential effects of medicinal cannabis on mental health: A systematic review. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 40186931
  5. Pharmacotherapies for cannabis dependence. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 30687936
  6. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. narrative or expert review; evidence still limited / 1 linked research note PubMed 19367504
  7. [Cannabis use and cannabis use disorders]. narrative or expert review; evidence still limited / 1 linked research note PubMed 39134752
  8. Pharmacotherapies for cannabis dependence. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 25515775
  9. Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 36434879